Researchers including CCDTR investigator Andrew Davis find three-target risk control in an RCT eliminated survival disparities in patients with initially poor control

October 2013 – A team of investigators including CCDTR investigator Dr. Andy Davis found that in a randomized controlled trial (RCT), significant race/ethnic differences in cardiac risk profiles that persisted during follow-up did not result in significant differences in 5-year death or death/MI/stroke. The findings were published in The American Journal of Cardiology. The article can be accessed here.